Correction: Klotho is a novel marker and cell survival factor in a subset of triple negative breast cancers (Oncotarget (2016) 7 (2611-2628) DOI: 10.18632/oncotarget.6006)

Nuša Trošt, Samuel Peña-Llopis, Sajjan Koirala, Jurij Stojan, Patrick Ryan Potts, Klementina Fon Tacer, Elisabeth D. Martinez

Research output: Contribution to journalComment/debatepeer-review

1 Scopus citations

Abstract

This article has been corrected: The correct Keywords are given below: Keywords: LCTL; gamma Klotho; FGF; breast cancer; cancer therapy; ROS; oxidative stress; oncogene.

Original languageEnglish (US)
Pages (from-to)916
Number of pages1
JournalOncotarget
Volume10
Issue number8
StatePublished - Jan 1 2019

ASJC Scopus subject areas

  • Oncology

Fingerprint

Dive into the research topics of 'Correction: Klotho is a novel marker and cell survival factor in a subset of triple negative breast cancers (Oncotarget (2016) 7 (2611-2628) DOI: 10.18632/oncotarget.6006)'. Together they form a unique fingerprint.

Cite this